Search Our Site

News filed in:

"medical"

Gene Therapy Creates Replacement Skin to Save a Dying Boy

Doctors in Europe used gene therapy to grow sheets of healthy skin that saved the life of a boy with a genetic disease that had destroyed most of his skin, the team reported on Wednesday in the journal Nature. This was not the first use of the treatment, which adds gene therapy to a technique... Read More »

Read More →

Doctors in Europe used gene therapy to grow sheets of healthy skin that saved the life of a boy with a genetic disease that had destroyed most of his skin, the team reported on Wednesday in the journal Nature. This was not the first use of the treatment, which adds gene therapy to a technique… Read More »

[...]

Read More

Whistleblower lawsuit claims Epic caused hundreds of hospitals to double-bill anesthesia services

A recently unsealed whistleblower lawsuit claims Epic’s billing software prompted hundreds of hospitals across the country to double-bill Medicare and Medicaid for anesthesia services, prompting “hundreds of millions of dollars” in fraudulent payments. The lawsuit, originally filed in 2015, was unsealed on Thursday. The federal government declined to intervene in the case earlier this year, but the... Read More »

Read More →

A recently unsealed whistleblower lawsuit claims Epic’s billing software prompted hundreds of hospitals across the country to double-bill Medicare and Medicaid for anesthesia services, prompting “hundreds of millions of dollars” in fraudulent payments. The lawsuit, originally filed in 2015, was unsealed on Thursday. The federal government declined to intervene in the case earlier this year, but the… Read More »

[...]

Read More

Teenager’s sickle cell reversed with world-first therapy

A French teenager’s sickle cell disease has been reversed using a pioneering treatment to change his DNA. The world-first procedure at Necker Children’s Hospital in Paris offers hope to millions of people with the blood disorder. Scientists altered the genetic instructions in his bone marrow so it made healthy red blood cells. So far, the... Read More »

Read More →

A French teenager’s sickle cell disease has been reversed using a pioneering treatment to change his DNA. The world-first procedure at Necker Children’s Hospital in Paris offers hope to millions of people with the blood disorder. Scientists altered the genetic instructions in his bone marrow so it made healthy red blood cells. So far, the… Read More »

[...]

Read More

Flabby heart keeps pumping with squeeze from robotic sleeve

WASHINGTON (AP) – Scientists are developing a robotic sleeve that can encase a flabby diseased heart and gently squeeze to keep it pumping. So far it’s been tested only in animals, improving blood flow in pigs. But this “soft robotic” device mimics the natural movements of a beating heart, a strategy for next-generation treatments of... Read More »

Read More →

WASHINGTON (AP) – Scientists are developing a robotic sleeve that can encase a flabby diseased heart and gently squeeze to keep it pumping. So far it’s been tested only in animals, improving blood flow in pigs. But this “soft robotic” device mimics the natural movements of a beating heart, a strategy for next-generation treatments of… Read More »

[...]

Read More

US organ transplants increased nearly 20% in five years

Organ transplants performed in the United States reached a record high during 2016, for the fourth year in a row, according to preliminary data from the United Network for Organ Sharing. During 2016, there were 33,606 transplants, an 8.5% increase over 2015 and up 19.8% since 2012. This growth can be mostly attributed to an... Read More »

Read More →

Organ transplants performed in the United States reached a record high during 2016, for the fourth year in a row, according to preliminary data from the United Network for Organ Sharing. During 2016, there were 33,606 transplants, an 8.5% increase over 2015 and up 19.8% since 2012. This growth can be mostly attributed to an… Read More »

[...]

Read More

Johnson & Johnson hit with $1 billion verdict for Pinnacle hip implants

Medical device manufacturer Johnson & Johnson and its DePuy Orthopedics division were again found liable for injuries stemming from the Pinnacle metal-on-metal hip implant. A Texas jury determined the company should pay $1.041 billion to the six plaintiffs whose cases were heard over the last two months. The jury in the third bellwether trial for... Read More »

Read More →

Medical device manufacturer Johnson & Johnson and its DePuy Orthopedics division were again found liable for injuries stemming from the Pinnacle metal-on-metal hip implant. A Texas jury determined the company should pay $1.041 billion to the six plaintiffs whose cases were heard over the last two months. The jury in the third bellwether trial for… Read More »

[...]

Read More

Chargemaster Still a Revenue Engine for Hospitals

Hospitals continue to use chargemaster updates to maximize revenue from commercial and self-pay patients, researchers find. Hospitals charged more than 20 times their actual costs for some services, including CT scans and anesthesiology services, according to research from two Johns Hopkins researchers which was published recently in Health Affairs. The study authors refuted the belief,... Read More »

Read More →

Hospitals continue to use chargemaster updates to maximize revenue from commercial and self-pay patients, researchers find. Hospitals charged more than 20 times their actual costs for some services, including CT scans and anesthesiology services, according to research from two Johns Hopkins researchers which was published recently in Health Affairs. The study authors refuted the belief,… Read More »

[...]

Read More

AbbVie to Seek Approval for Potential Blockbuster Leukemia Drug

(Reuters) – AbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its primary goal in a mid-stage trial and that the company would seek U.S. approval of the medicine, which analysts have said has blockbuster sales potential. AbbVie, which is developing the drug venetoclax with... Read More »

Read More →

(Reuters) – AbbVie Inc on Wednesday said its experimental treatment for a form of leukemia associated with a gene mutation met its primary goal in a mid-stage trial and that the company would seek U.S. approval of the medicine, which analysts have said has blockbuster sales potential. AbbVie, which is developing the drug venetoclax with… Read More »

[...]

Read More

Parkinson’s Disease: Could A Drug For Liver Disease Slow Its Progression?

New findings published in the journal Neurology reveal that a liver drug could help to slow the progression of Parkinson’s Disease. Researchers found that the drug ursodeoxycholic acid, which is used to decrease acids that are involved in liver disease, could address a mutation of the LRRK2 gene, which is commonly inherited via Parkinson’s disease.... Read More »

Read More →

New findings published in the journal Neurology reveal that a liver drug could help to slow the progression of Parkinson’s Disease. Researchers found that the drug ursodeoxycholic acid, which is used to decrease acids that are involved in liver disease, could address a mutation of the LRRK2 gene, which is commonly inherited via Parkinson’s disease…. Read More »

[...]

Read More

The scarcity of kidneys for transplantation and high mortality among patients on the waiting list have led some patients to accept kidney transplants that carry elevated risks of transmitting infections or cancer. In certain cases, such as the transmission of cytomegalovirus, physicians can anticipate these events and institute preventive measures. But transplant teams often discard… Read More »

[...]

Read More

Page 1 of 11

Categories
Archives